Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-08 07:57 am Sale |
2025-03-31 | 13G | TELA Bio, Inc. TELA |
Orin Hirschman | 1,416,323 3.600% |
-1,246,462 (-46.81%) |
Filing History |
| 2025-05-08 07:51 am Purchase |
2025-03-31 | 13G | Grace Therapeutics, Inc. GRCE |
Orin Hirschman | 1,322,379 9.900% |
801,296 (+153.78%) |
Filing History |
| 2025-05-08 07:44 am Purchase |
2025-03-31 | 13G | RenovoRx, Inc. RNXT |
Orin Hirschman | 3,467,275 9.500% |
3,467,275 (New Position) |
Filing History |
| 2025-05-08 07:39 am Purchase |
2025-03-31 | 13G | BiomX Inc. PHGE |
Orin Hirschman | 1,566,944 6.300% |
1,566,944 (New Position) |
Filing History |
| 2025-02-25 4:05 pm Purchase |
2024-12-31 | 13G | DROR ORTHO-DESIGN, INC. DROR |
Orin Hirschman | 95,662,500 9.900% |
47,000,000 (+96.58%) |
Filing History |
| 2025-02-10 08:38 am Purchase |
2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Orin Hirschman | 255,555 8.500% |
255,555 (New Position) |
Filing History |
| 2025-02-10 08:36 am Purchase |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Orin Hirschman | 539,300 9.900% |
190,000 (+54.39%) |
Filing History |
| 2025-02-10 08:35 am Purchase |
2024-12-31 | 13G | Coya Therapeutics, Inc. COYA |
Orin Hirschman | 1,333,919 8.000% |
169,547 (+14.56%) |
Filing History |
| 2025-02-10 08:33 am Purchase |
2024-12-31 | 13G | Ideal Power Inc. IPWR |
Orin Hirschman | 823,315 9.900% |
123,315 (+17.62%) |
Filing History |
| 2025-02-10 08:30 am Purchase |
2024-12-31 | 13G | Myomo, Inc. MYO |
Orin Hirschman | 3,381,567 9.900% |
543,277 (+19.14%) |
Filing History |
| 2025-02-10 08:29 am Sale |
2024-12-31 | 13G | Personalis, Inc. PSNL |
Orin Hirschman | 4,293,639 6.100% |
-100,425 (-2.29%) |
Filing History |
| 2025-02-10 08:27 am Sale |
2024-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Orin Hirschman | 560,905 9.500% |
-7,776 (-1.37%) |
Filing History |
| 2025-02-10 08:24 am Sale |
2024-12-31 | 13G | Theratechnologies Inc. THTX |
Orin Hirschman | 3,026,569 6.100% |
-692,733 (-18.63%) |
Filing History |
| 2025-02-04 08:53 am Sale |
2024-12-31 | 13G | SmartKem, Inc. SMTK |
Orin Hirschman | 362,784 9.900% |
-17,417 (-4.58%) |
Filing History |
| 2025-02-03 8:07 pm Purchase |
2024-12-31 | 13G | SmartKem, Inc. SMTK |
Orin Hirschman | 380,201 9.900% |
243,264 (+177.65%) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | Intellicheck, Inc. IDN |
Orin Hirschman | 1,617,696 8.200% |
18,743 (+1.17%) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Orin Hirschman | 4,200,577 8.400% |
1,093,782 (+35.21%) |
Filing History |
| 2025-01-31 4:05 pm Sale |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 6,191,865 8.500% |
-546,067 (-8.10%) |
Filing History |
| 2025-01-31 4:05 pm Unchanged |
2024-12-31 | 13G | LightPath Technologies, Inc. LPTH |
Orin Hirschman | 3,723,932 9.400% |
0 (Unchanged) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Orin Hirschman | 2,662,785 6.800% |
1,284,840 (+93.24%) |
Filing History |